Ola Rominiyi

1.6k total citations
22 papers, 341 citations indexed

About

Ola Rominiyi is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Ola Rominiyi has authored 22 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Ola Rominiyi's work include Glioma Diagnosis and Treatment (11 papers), DNA Repair Mechanisms (4 papers) and PARP inhibition in cancer therapy (4 papers). Ola Rominiyi is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), DNA Repair Mechanisms (4 papers) and PARP inhibition in cancer therapy (4 papers). Ola Rominiyi collaborates with scholars based in United Kingdom, United States and Nigeria. Ola Rominiyi's co-authors include Spencer J. Collis, Yahia Al-Tamimi, Susan Clenton, Katie Myers, Ahmed K. Awad, Ramez Kirollos, Ajai Chari, Michael T. C. Poon, Olaoluwa Ezekiel Dada and Abdurrahman I. Islim and has published in prestigious journals such as BMJ, British Journal of Cancer and British journal of surgery.

In The Last Decade

Ola Rominiyi

21 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ola Rominiyi United Kingdom 8 136 108 79 56 51 22 341
Guifa Xi United States 11 100 0.7× 192 1.8× 83 1.1× 66 1.2× 33 0.6× 21 442
Adrian Kinzel United States 9 192 1.4× 95 0.9× 136 1.7× 71 1.3× 39 0.8× 35 401
Narasimha Kumar Karanam United States 8 135 1.0× 158 1.5× 108 1.4× 77 1.4× 16 0.3× 19 395
Einav Zeevi United States 8 193 1.4× 142 1.3× 178 2.3× 91 1.6× 32 0.6× 33 465
M. Suzette Blanchard United States 8 89 0.7× 110 1.0× 60 0.8× 111 2.0× 55 1.1× 13 308
Joseph Shan United States 10 113 0.8× 104 1.0× 37 0.5× 83 1.5× 51 1.0× 24 401
Uday Bhanu Maachani United States 13 149 1.1× 257 2.4× 33 0.4× 108 1.9× 73 1.4× 20 533
Anton Wohl Israel 8 62 0.5× 145 1.3× 55 0.7× 24 0.4× 49 1.0× 14 304
Keith Killian United States 10 65 0.5× 203 1.9× 59 0.7× 125 2.2× 117 2.3× 24 448
Claus Dittmar Germany 10 274 2.0× 185 1.7× 47 0.6× 64 1.1× 46 0.9× 14 599

Countries citing papers authored by Ola Rominiyi

Since Specialization
Citations

This map shows the geographic impact of Ola Rominiyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Rominiyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Rominiyi more than expected).

Fields of papers citing papers by Ola Rominiyi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Rominiyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Rominiyi. The network helps show where Ola Rominiyi may publish in the future.

Co-authorship network of co-authors of Ola Rominiyi

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Rominiyi. A scholar is included among the top collaborators of Ola Rominiyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Rominiyi. Ola Rominiyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dada, Olaoluwa Ezekiel, Sophie Williams, Shungu Ushewokunze, et al.. (2025). Race and “omic” data in glioma: A systematic review of contemporary research to explore the digital divide. Neuro-Oncology Practice. 12(4). 585–599. 1 indexed citations
2.
Myers, Katie, Ola Rominiyi, Spencer J. Collis, et al.. (2024). SENP3-FIS1 axis promotes mitophagy and cell survival under hypoxia. Cell Death and Disease. 15(12). 881–881. 2 indexed citations
4.
Myers, Katie, et al.. (2023). DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells. British Journal of Cancer. 129(11). 1829–1840. 7 indexed citations
5.
Williams, Sophie, Samantha Conroy, Ola Rominiyi, et al.. (2022). Precision oncology using ex vivo technology: a step towards individualised cancer care?. Expert Reviews in Molecular Medicine. 24. e39–e39. 10 indexed citations
6.
Dada, Olaoluwa Ezekiel, Setthasorn Zhi Yang Ooi, Chi Le, et al.. (2022). Evaluating the Impact of Neurosurgical Rotation Experience in Africa on the Interest and Perception of Medical Students Towards a Career in Neurosurgery: A Continental, Multi-Centre, Cross-Sectional Study. Frontiers in Surgery. 9. 766325–766325. 23 indexed citations
7.
Gillespie, Conor S., Michael T. C. Poon, Georgios Solomou, et al.. (2022). Imaging timing after glioblastoma surgery (INTERVAL-GB): protocol for a UK and Ireland, multicentre retrospective cohort study. BMJ Open. 12(9). e063043–e063043. 5 indexed citations
8.
Myers, Katie, Dennis Wang, Mark Dunning, et al.. (2022). STEM-02. GENERATION AND CHARACTERISATION OF A LIVING BIOBANK OF POST-SURGICAL RESIDUAL GLIOBLASTOMA TO IDENTIFY NOVEL THERAPEUTIC TARGETS. Neuro-Oncology. 24(Supplement_7). vii31–vii31.
9.
Dada, Olaoluwa Ezekiel, Setthasorn Zhi Yang Ooi, Chi Hieu Le, et al.. (2022). 814 Evaluating the Impact of Neurosurgical Rotation Experience in Africa on the Interest and Perception of Medical Students Towards a Career in Neurosurgery: A Continental, Multi-Centre, Cross-Sectional Study. British journal of surgery. 109(Supplement_6). 2 indexed citations
11.
Rominiyi, Ola, et al.. (2021). Correction: Tumour treating fields therapy for glioblastoma: current advances and future directions. British Journal of Cancer. 125(4). 623–623. 2 indexed citations
12.
Rominiyi, Ola, Katie Myers, Sherif F. El‐Khamisy, et al.. (2021). Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma. Cancers. 13(5). 944–944. 12 indexed citations
13.
Rominiyi, Ola, et al.. (2020). Tumour treating fields therapy for glioblastoma: current advances and future directions. British Journal of Cancer. 124(4). 697–709. 202 indexed citations
14.
Mohan, Midhun, Abdurrahman I. Islim, Ola Rominiyi, et al.. (2019). Subarachnoid haemorrhage with negative initial neurovascular imaging: a systematic review and meta-analysis. Acta Neurochirurgica. 161(10). 2013–2026. 20 indexed citations
15.
Hardman, Simon, et al.. (2019). Is cranial computed tomography unnecessary in children with a head injury and isolated vomiting?. BMJ. 365. l1875–l1875. 5 indexed citations
16.
Rominiyi, Ola, Yahia Al-Tamimi, & Spencer J. Collis. (2019). The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong?. Cancers. 11(3). 426–426. 8 indexed citations
17.
Rominiyi, Ola, Katie Myers, Natividad Gomez-Roman, et al.. (2019). RDNA-12. THE FANCONI ANAEMIA (FA) PATHWAY AND GLIOBLASTOMA: A NEW FOUNDATION FOR DNA DAMAGE RESPONSE TARGETED COMBINATIONS. Neuro-Oncology. 21(Supplement_6). vi209–vi209. 3 indexed citations
18.
Rominiyi, Ola, et al.. (2018). P04.74 Preclinical evaluation of combinations targeting the DNA damage response in 2D and 3D models of glioblastoma stem cells. Neuro-Oncology. 20(suppl_3). iii297–iii297. 2 indexed citations
19.
Rominiyi, Ola, et al.. (2018). FA-based combinations to target the DNA damage response in glioblastoma. Neuro-Oncology. 20(suppl_5). v358–v358. 1 indexed citations
20.
Rominiyi, Ola, et al.. (2011). Colon cancer presenting with polymyositis—A case report. International Journal of Surgery Case Reports. 2(7). 225–227. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026